Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
📧 Sign up to get email alerts when something new happens for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
This completed clinical trial update reports an imaging study investigating neurovascular coupling in CADASIL. The sponsor is INSERM (France…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Efficacy and Safety of Tocotrienols in CADASIL [Phase 2]
A Phase 2 clinical trial assessing the efficacy and safety of tocotrienols in CADASIL has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: CERebrolysin In CADASIL [Phase 2]
Phase 2 trial update for CERebrolysin in CADASIL; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment [Phase 2]
Completed Phase 2 trial evaluating the efficacy, safety, and tolerability of donepezil hydrochloride in patients with CADASIL and cognitive …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
A clinical trial investigating CADASIL has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.